Epilepsy & Seizures
Conference Coverage
Enzyme-inducing AEDs may raise vitamin D dose requirements
NEW ORLEANS – Patients taking enzyme-inducing antiepileptic drugs required 1,587 units/day of vitamin D to meet the goal – a 409-unit increase in...
Conference Coverage
Teenagers with epilepsy may benefit from depression screening
NEW ORLEANS – As much as 8% of patients with pediatric epilepsy may have moderately severe depressive symptoms, and...
Conference Coverage
Depression is linked to seizure frequency in patients with epilepsy
NEW ORLEANS – Screen patients with epilepsy for psychiatric comorbidities.
From the Journals
Model may predict prolonged status epilepticus outcomes
The two-variable model must now undergo external validation.
From the Journals
AEDs strongly linked to rare serious skin reactions
The highest-risk AEDs were zonisamide, rufinamide, clorazepate, lamotrigine, carbamazepine, and phenytoin.
Conference Coverage
OV-101 shows promise for Angelman syndrome
A novel drug affecting the GABAergic system improved sleep problems in a sample of adults and adolescents with Angelman Syndrome.
FDA/CDC
FDA approves Sympazan for Lennox-Gastaut syndrome
Patients with Lennox-Gastaut syndrome can have difficulty swallowing pills or large-volume oral suspensions, so this oral film may reduce care...
Article
DEA Reclassifies Epidiolex as Schedule V
WASHINGTON, DC—The Drug Enforcement Administration (DEA) has reclassified Epidiolex, an oral cannabidiol (CBD) solution...
Conference Coverage
Rapid Sequence MRI May Hold Advantages for Neonates With Seizures
CHICAGO—Use of rapid sequence MRI in the evaluation of neonates with seizures and no hypoxic-ischemic...
Latest News
Funding for NIH BRAIN Initiative reaches new heights
Literature Review
Modeling Favors Immediate AED Treatment After an Unprovoked First Seizure
Immediate treatment of a first unprovoked seizure may be preferable to delayed treatment over a wide range of patients,...